On 28 September, on the eve of its general assembly, BIO Deutschland invited its member companies and Bundestag members to a parliamentary evening in the Käfer restaurant on the roof of the Reichstag building in Berlin.
The current shortage of skilled workers is also felt strongly in the highly innovative biotechnology sector, according to a survey of biotechnology companies conducted by BIO Deutschland ahead of the HR in Life Science & Healthcare Conference. When it comes to the core of biotechnology – scientific research and development (R&D) – everything appears to be more or less in order, but companies described the situation in the technical and marketing areas as increasingly difficult.
The gross value added in the medical biotechnology segment rose by 12.5 percent to €10.2 billion in 2021, reaching a new all-time high. The segment also saw growth in employment numbers.